L-carnitine prevents ammonia-induced cytotoxicity and disturbances in intracellular amino acid levels in human astrocytes.


Journal

Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 06 03 2018
revised: 04 09 2018
accepted: 19 09 2018
pubmed: 3 10 2018
medline: 30 1 2020
entrez: 3 10 2018
Statut: ppublish

Résumé

L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear. Thus, the cytotoxicity and changes in intracellular amino acids (AAs) in astrocytes with hyperammonemia following L-CA administration were studied. Human astrocytes were treated with ammonium chloride (NH Intracellular total reactive oxygen species and lactate dehydrogenase leakage were significantly increased after treatment with NH L-CA protects human astrocytes from ammonia-induced acute cytotoxic effects and the increased intracellular levels of glutamine and BCAAs.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear. Thus, the cytotoxicity and changes in intracellular amino acids (AAs) in astrocytes with hyperammonemia following L-CA administration were studied.
METHODS METHODS
Human astrocytes were treated with ammonium chloride (NH
RESULTS RESULTS
Intracellular total reactive oxygen species and lactate dehydrogenase leakage were significantly increased after treatment with NH
CONCLUSION CONCLUSIONS
L-CA protects human astrocytes from ammonia-induced acute cytotoxic effects and the increased intracellular levels of glutamine and BCAAs.

Identifiants

pubmed: 30278111
doi: 10.1111/jgh.14497
doi:

Substances chimiques

Amino Acids, Branched-Chain 0
Neuroprotective Agents 0
Reactive Oxygen Species 0
Ammonium Chloride 01Q9PC255D
Glutamine 0RH81L854J
L-Lactate Dehydrogenase EC 1.1.1.27
Carnitine S7UI8SM58A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1249-1255

Subventions

Organisme : Grant-in-Aid for Scientific Research in Japan
ID : 25461009

Informations de copyright

© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Auteurs

Ting Wang (T)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.

Kazuyuki Suzuki (K)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.
Department of Nutritional Science, Morioka University, Takizawa, Japan.

Keisuke Kakisaka (K)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.

Mio Onodera (M)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.

Kei Sawara (K)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.

Yasuhiro Takikawa (Y)

Division of Hepatology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH